Search results
Appearance
There is a page named "N-terminal domain antiandrogen" on Wikipedia
- N-Terminal domain antiandrogens are a novel type of antiandrogen that bind to the N-terminal domain of the androgen receptor (AR) instead of the ligand-binding...1 KB (69 words) - 11:43, 11 January 2019
- Ralaniten (category Nonsteroidal antiandrogens)Ralaniten (developmental code name EPI-002) is an N-terminal domain antiandrogen which was never marketed. It is a derivative of bisphenol A and one of...3 KB (178 words) - 09:16, 3 December 2023
- Antiandrogens, also known as androgen antagonists or testosterone blockers, are a class of drugs that prevent androgens like testosterone and dihydrotestosterone...158 KB (15,043 words) - 06:11, 3 August 2024
- Masofaniten (category Nonsteroidal antiandrogens)developmental code name EPI-7386, is an N-terminal domain antiandrogen, or antagonist of the N-terminal domain (NTD) of the androgen receptor (AR), which...5 KB (400 words) - 19:17, 9 May 2024
- Selective androgen receptor modulator N-Terminal domain antiandrogen Discovery and development of antiandrogens Nonsteroidal estrogen Kolvenbag, Geert...17 KB (1,576 words) - 15:57, 24 February 2024
- inhibitor of the androgen receptor amino-terminal domain Ralaniten (EPI-002), an N-terminal domain antiandrogen which was never marketed This set index...380 bytes (66 words) - 02:46, 19 March 2021
- The first antiandrogen was discovered in the 1960s. Antiandrogens antagonise the androgen receptor (AR) and thereby block the biological effects of testosterone...42 KB (4,594 words) - 12:17, 24 February 2024
- Ralaniten acetate (category Nonsteroidal antiandrogens)(developmental code name EPI-506) is a first-in-class antiandrogen that targets the N-terminal domain (NTD) of the androgen receptor (AR) developed by ESSA...6 KB (423 words) - 19:25, 14 August 2023
- Androgen receptor (section Domains)nilutamide, bicalutamide, enzalutamide, apalutamide, RU-58841) N-Terminal domain antiandrogens (e.g., bisphenol A, EPI-001, ralaniten, JN compounds) The AR...87 KB (9,376 words) - 13:18, 19 August 2024
- 5N-Bicalutamide (category Nonsteroidal antiandrogens)antagonists to have been developed thus far. Cyanonilutamide N-Terminal domain antiandrogen de Jesus Cortez F, Nguyen P, Truillet C, Tian B, Kuchenbecker...5 KB (400 words) - 10:45, 3 November 2023
- Efforts are underway to assess ERX-11 in human clinical trials. N-Terminal domain antiandrogen Raj GV, Sareddy GR, Ma S, Lee TK, Viswanadhapalli S, Li R, et al...8 KB (733 words) - 01:54, 3 December 2023
- EPI-001 (category Nonsteroidal antiandrogens)is different from all currently-used antiandrogens, which, conversely, bind to the C-terminal ligand-binding domain (LBD) of the AR and competitively block...13 KB (1,307 words) - 13:20, 23 June 2023
- (pharmacodynamics, pharmacokinetics, and routes of administration) of the steroidal antiandrogen and progestin medication cyproterone acetate. CPA blocks the effects...118 KB (14,433 words) - 05:50, 27 December 2023
- the pharmacodynamic and pharmacokinetic properties of the nonsteroidal antiandrogen (NSAA) bicalutamide. In terms of pharmacodynamics, bicalutamide acts...185 KB (20,447 words) - 15:57, 1 August 2024
- various interaction partners of the ARM domains. The segments N-terminal and far C-terminal to the ARM domain do not adopt any structure in solution by...107 KB (12,362 words) - 22:48, 10 July 2024
- identified by Wanker et al. in 1997. HIP1 was found to bind to Htt in an N-terminal dependent manner, and co-localise with Htt in the CNS although the nature...6 KB (871 words) - 23:51, 3 March 2023
- Index of oncology articles (section N)anti-CEA antibody – anti-idiotype vaccine – anti-inflammatory – antiandrogen – antiandrogen therapy – anti-angiogenesis – antiangiogenic – antibody – antibody...69 KB (5,119 words) - 11:20, 3 June 2024
- of hCG have also been detected, including nicked hCG, hCG missing the C-terminal peptide from the beta-subunit, and free alpha-subunit, which has no known...49 KB (5,376 words) - 23:12, 24 August 2024
- around a central pore. Each subunit comprises four transmembrane domains with both the N- and C-terminus located extracellularly. The receptor sits in the...54 KB (5,844 words) - 13:37, 26 July 2024
- SHBG has two laminin G-like domains which form pockets that bind hydrophobic molecules. The steroids are bound by the LG domain at the amino end of the protein...57 KB (4,584 words) - 22:43, 2 August 2024